Bellevue | Küsnacht, 07.07.2016.
MARKET REVIEW
The Nasdaq Biotech Index (NBI) ended the month of June down -7.8% in USD. BB Biotech’s NAV was down -6.8% in USD, -8.3% in CHF and down -6.4% in EUR. BB Biotech’s share price was down -8.1% in USD, down -9.5% in CHF and -7.2% in EUR.
After a short recovery in May, markets have been shaken again in June, following the unexpected “Brexit” vote from the UK. Investors were caught off-guard by the result of the EU referendum and markets crashed the day after, even though economic and political questions raised by this vote will not be answered for years.